Data / Form D filings / GEN1E LIFESCIENCES INC.
GEN1E LIFESCIENCES INC.: Form D filings
GEN1E LIFESCIENCES INC., a biotechnology company in Palo Alto, CA, filed 2 Form D notices with the SEC between 2022 and 2025. The latest, on December 29, 2025, reports $5.5 million sold of a $11.9 million offering to 44 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1895 El Camino Real, Palo Alto, CA, 94306
- Phone
- (650) 799-7121
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1752886
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 29, 2025 | New notice | $11,887,377 | $5,520,803 | $6,366,574 | 44 | Oct 21, 2025 | sec.gov |
| Dec 21, 2022 | New notice | $18,223,556 | $17,025,023 | $1,198,533 | 89 | Dec 6, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ritu Lal | Executive Officer, Director | |
| Francois Nader | Director | |
| Alan Levy | Director | |
| Noor Kamruddin | Director | |
| Soujanya Bhumkar | Executive Officer, Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Dec 29, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GEN1E LIFESCIENCES INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.